Company to Host Conference Call on November 10, 2025, at 4:30 p.m. ETSAN DIEGO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Capricor ...

Publication highlights Deramiocel’s anti-fibrotic activity and describes a validated potency assay supporting quality control and product ...

The FDA is said to be making a U-turn on uniQure’s one-time gene therapy candidate for Huntington’s disease despite the treatment being hailed as a game-changer. | FDA is said to be making a U-turn on ...

But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt. Given this risk, we thought we'd take a look at whether Capricor Therapeutics (NASDAQ:CAPR) ...

Capricor Therapeutics finds itself navigating turbulent waters as a federal securities class action lawsuit casts uncertainty over the company's future. The legal investigation, made public on October ...

Novartis AG will acquire Avidity Biosciences, Inc. for $12B, aiming to strengthen its neuroscience franchise. Learn more ...

Detailed price information for Shionogi & Co. Ltd (SGIOF) from The Globe and Mail including charting and trades.

Detailed price information for Bank of Communications Co. Ltd (BKFCF) from The Globe and Mail including charting and trades.